We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACN icon
351
Accenture
ACN
$94.3B
$860K 0.1%
+2,432
New +$800K
IESC icon
352
IES Holdings
IESC
$12B
$859K 0.1%
4,302
-1,739
-29% -$282K
MTZ icon
353
MasTec
MTZ
$26.6B
$858K 0.1%
+6,973
New +$761K
KRYS icon
354
Krystal Biotech
KRYS
$10.4B
$856K 0.1%
4,705
+3,513
+295% +$677K
SMPL icon
355
Simply Good Foods
SMPL
$943M
$855K 0.1%
24,601
+9,726
+65% +$330K
CHRW icon
356
C.H. Robinson
CHRW
$20.6B
$853K 0.1%
+7,726
New +$750K
FROG icon
357
JFrog
FROG
$9.84B
$851K 0.1%
29,290
+9,757
+50% +$307K
OSW icon
358
OneSpaWorld
OSW
$2.76B
$847K 0.1%
51,328
+22,264
+77% +$353K
NUS icon
359
Nu Skin
NUS
$250M
$847K 0.1%
+114,962
New +$1.07M
FHI icon
360
Federated Hermes
FHI
$4.5B
$845K 0.1%
22,986
-30,458
-57% -$1.04M
MATX icon
361
Matsons
MATX
$6.22B
$844K 0.1%
+5,917
New +$778K
RTX icon
362
RTX Corp
RTX
$294B
$844K 0.1%
+6,965
New +$794K
IOVA icon
363
Iovance Biotherapeutics
IOVA
$2.19B
$843K 0.1%
89,790
-25,193
-22% -$239K
OSG
364
Octave Specialty Group
OSG
$258M
$843K 0.1%
75,208
-6,903
-8% -$80.7K
COP icon
365
ConocoPhillips
COP
$141B
$843K 0.1%
8,004
-2,420
-23% -$266K
NABL icon
366
N-able
NABL
$823M
$843K 0.1%
64,521
-37,235
-37% -$498K
STRL icon
367
Sterling Infrastructure
STRL
$19.5B
$840K 0.1%
5,790
-6,792
-54% -$807K
LZ icon
368
LegalZoom.com
LZ
$1.3B
$838K 0.1%
132,026
+98,767
+297% +$647K
MGRC icon
369
McGrath RentCorp
MGRC
$2.95B
$838K 0.1%
+7,962
New +$844K
TWO
370
Two Harbors Investment
TWO
$1.27B
$838K 0.1%
+60,357
New +$823K
JBTM
371
JBT Marel
JBTM
$7.37B
$833K 0.1%
+8,455
New +$781K
LAZ icon
372
Lazard
LAZ
$4.23B
$832K 0.1%
+16,523
New +$765K
IVT icon
373
InvenTrust Properties
IVT
$2.83B
$832K 0.1%
+29,311
New +$813K
AOS icon
374
A.O. Smith
AOS
$8.61B
$831K 0.1%
+9,254
New +$766K
CSR
375
Centerspace
CSR
$937M
$831K 0.1%
+11,790
New +$848K
13 14
15
16 17

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.